May 1, 2013

Safety, cost savings, simplicity back broader use of bloodless surgery

By: OR Manager
Surgery  
PDF
Share

More than 120 centers throughout the US have bloodless surgery programs to serve patients who refuse blood transfusions for religious and other reasons. The practice, which began more than 50 years ago, has evolved through research on blood conservation and new techniques to minimize the need for transfusions.

The Joint Commission is taking a serious look at reducing transfusions, which could spur the growth of blood management and bloodless surgery programs across the country, says Mark Zawadsky, MD, medical director of the Bloodless Medicine and Surgery program at Georgetown University Hospital in Washington, DC.

Blood management has also attracted the attention of the AABB (formerly the American Association of Blood Banks) and the Department of Health and Human Services (HHS).

 

Many transfusions unnecessary, costly

The HHS Advisory Committee on Blood Safety and Availability issued findings and recommendations in June 2011.

Among the findings was that too many patients are receiving blood transfusions that they don’t need, putting them at risk, wasting limited blood resources, and raising costs.

More than 15 million units of whole blood and red blood cells are transfused annually in the US according to HHS, and as many as 30% of transfusions may be unnecessary.

In 2011, the Implementation Guide for The Joint Commission Patient Blood Management Performance Measures was developed to target indications and screening for blood transfusions (http://www.jointcommission.org/patient_blood_management_performance_measures_project/).

Though use of the measures is not an accreditation requirement, participants at a national summit on overuse of blood transfusions, held in 2012 by the American Medical Association and the Joint Commission, called for implementation of the measures at the local and national levels.

 

‘Build it and they will come’

Several hospitals have been pioneers in bloodless surgery.

Three years ago, Georgetown University Hospital responded to the needs of the Jehovah’s Witness community, which lacked a bloodless center in the DC area.

The Witness community provided organizational support for the program as it was being established, which includes a medical director, nurse coordinator, secretary, and an administrative coordinator.

“We put together hospital protocols and policies to help streamline the process, so when patients who want to avoid blood transfusions come to us, we can immediately tell them the procedures we offer,” says Dr Zawadsky.

More than 200 patients a year undergo bloodless surgery at Georgetown, and about 10% come from outside the Witness community. In the past year, Dr Zawadsky, an orthopedic surgeon, performed some 25 hip and knee replacements in patients in the bloodless program.

“A lot of what we are doing is simply basic good medicine, and it doesn’t have to be just for patients who are bloodless surgery patients. All patients can benefit from these techniques,” he says.

When starting a program, Dr Zawadsky recommends involving the anesthesia department. Anesthesiologists evaluate patients preoperatively, manage them during surgery, and follow up with them in the postanesthesia care unit (PACU). He believes that if you have an anesthesia champion to push the benefits of giving less blood, surgeons may be encouraged to operate this way.

 

Major strategies

Bloodless surgery at Georgetown and other hospitals consists of 3 strategies (sidebar):

• Preoperative anemia management—administering IV iron or Procrit (epoetin alfa, a synthetic form of the protein human erythropoietin that stimulates bone marrow to make more red blood cells) and discontinuing antiplatelet medications and supplements.

• Intraoperative techniques to minimize loss of red blood cells—normovolemic hemodilution and cell salvage.

• Postoperative conservation of patients’ blood and anemia management—restriction of blood draws for lab tests and administration of IV iron or Procrit if necessary.

“The strategies we use to prepare patients for bloodless surgery are low-tech and common sense,” says Patricia Ford, MD, an oncologist/hematologist and medical director of the Center for Bloodless Medicine and Surgery at Pennsylvania Hospital, Philadelphia.

Every year, Dr Ford guides some 700 patients through procedures from heart surgery to hysterectomies without transfusions.

About 95% of Dr Ford’s patients decline a transfusion based on religious convictions, but an additional 5% decline for other reasons, such as fear of bloodborne infections.

 

Blood management cost-effective

“Blood is expensive—costing about $1,100 to acquire and administer 1 unit,” says Sherri Ozawa, RN, clinical director of the Institute for Patient Blood Management at Englewood Hospital and Medical Center in Englewood, New Jersey.

“If a hospital’s blood budget is $5 million a year, and they decrease it by 10% to 20%, that is a significant savings,” she says.

Research by Ozawa and colleagues (Shander et al, 2010), found annual expenditures for blood and transfusion-related activities for surgical patients ranged from $1.62 million to $6.03 million per hospital.

Englewood Hospital started its bloodless surgery program in 1994, and 2 years later, blood use had dropped by 40%.

 

Transfusion poses risks

Evidence is growing that blood transfusions are associated with increased postoperative morbidity and mortality (sidebar).

According to the most recent National Blood Collection and Utilization Survey, funded by HHS and conducted by the AABB, the annual number of adverse effects from transfusions that required any diagnostic or therapeutic intervention was 60,110, or 1 in 394 transfusions.

In 2012, the health alliance Premier found that use of blood products beyond a level deemed medically necessary can increase complication rates and length of hospitalization. Premier recommends industry-wide standardization of blood utilization practices.

Ozawa notes that, conceptually, blood is “really a liquid organ transplant that’s treated as a medicine used to manage anemia. It is the only transplant that can be administered by nurses.”



Autologous blood not used

Preoperative autologous blood donation is not used for patients in bloodless surgery programs.

“All it does is make the patient anemic,” says Dr Ford.

Many patients mistakenly believe that their own blood is 100% safe because it’s theirs, she says. However, human error can make any transfusion risky. The lab can confuse the blood samples, the blood bank can issue the wrong unit of blood, or the nurse or physician can administer the blood to the wrong patient. The blood bank may not label the blood correctly, store it correctly, or return it to the correct patient.

A new Johns Hopkins study on shelf life (Frank et al, 2013) found that red blood cells stored longer than 3 weeks begin to lose their capacity to deliver oxygen to tissue, and these changes are not readily reversible after transfusion.

“When blood is stored for a prolonged period of time, the red cells deteriorate,” says Dr Ford. “They lose enzymes, and don’t carry oxygen as well as they should. They also become deformed and don’t travel through small blood vessels as well as they should.”

 

Transfusion restrictions

In March 2012, the AABB released a clinical practice guideline on red blood cell transfusion that focused on a restrictive transfusion strategy and the use of patient symptoms as well as hemoglobin concentration to trigger transfusions (http://annals.org/article.aspx?articleid=1103943).

A hemoglobin transfusion trigger of 10 g/dL had been the standard since the 1940s.

The first study to challenge this standard, the Transfusion Requirements in Critical Care (TRICC) trial, was performed in 1999 by Hebert et al. The study compared outcomes in intensive care patients transfused when hemoglobin concentrations dropped below 7 g/dL (restrictive group) and those transfused when hemoglobin concentrations were below 10 g/dL (liberal group). The restrictive group had lower overall 30-day mortality and lower in-hospital mortality rates.

A 2011 study by Carson et al confirmed these findings and showed the results also apply to elderly surgical patients with cardiovascular risks. More than 2,000 hip fracture patients with a cardiac history were transfused at either a hemoglobin of 10 g/dL or <8 g/dL. Results showed no difference between the 2 groups in morbidity, mortality, or rehabilitation milestones, but wound infection rates were almost twice as high for the more liberal strategy of 10 g/dL.

 

Are triggers necessary?

“A patient’s hemoglobin can go very low, and the body can still support adequate tissue oxygenation, and the patient can survive without a transfusion,” says Dr Ford.

Pennsylvania Hospital statistics from 2007 showed that in patients with hemoglobins of 4 g/dL, no deaths were directly related to withholding blood products. Even at hemoglobins of 2 g/dL and 3 g/dL, survival rates were 50% and 70%, respectively, says Dr Ford.

The hospital saw the number of transfusions immediately lowered by 10% when it modified its guideline from 8 g/dL to 7 g/dL about 2 years ago and began requiring the physician ordering the transfusion to cite a reason if the hemoglobin was above 7 g/dL. An additional modification to order 1 unit of blood at a time and reassess the patient before ordering a second unit also helped lower the number of transfusions.

Georgetown’s trigger for transfusion is a hemoglobin of 7.5 g/dL, and staff now order and transfuse 1 unit of blood, then check the hemoglobin before ordering a second unit.

Englewood Hospital’s policy does not have a hemoglobin level trigger for transfusion, but most physicians use 7 g/dL, says Ozawa.

“We believe the decision to transfuse needs to be a physiological decision, not a numbers-based decision. There are patients who do fine with a hemoglobin of 5 g/dL and others who have problems at 11 g/dL.”

 

Simple strategies

Strategies for bloodless surgery patients are simple to implement, can decrease unnecessary blood transfusions, and can save on health care costs for all patients, says Dr Ford.

These include:

• Correct anemia preoperatively.

• Eliminate unnecessary blood tests.

• Don’t transfuse based solely on a number; use clinical assessment as to whether a unit of blood is necessary.

• Don’t automatically order 2 units of blood; give 1 unit and reassess the patient before ordering a second.

Applying these principles across the spectrum of surgical care could dramatically reduce all patients’ exposure to donor blood. ❖


 

References

Carson J L, Grossman B J, Kleinman S, et al. Red blood cell transfusion: A clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58.

http://annals.org/article.aspx?articleid=1103943

Carson J L, Terrin M L, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453-2462.

Frank S M, Abazyan B, Ono M, et al. Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesthes Analges. Published online February 28, 2013.

Hebert P C, Wells G, Blajchman M A, et al. A multicenter, randomized, controlled clinical trial of transfusion requirement in critical care (TRICC). N Engl J Med. 1999;340:409-417.

Implementation Guide for the Joint Commission Patient Blood Management Performance Measures 2011

http://www.jointcommission.org/patient_blood_management_performance_measures_project/

Joint Commission National Summit on Overuse: September 24, 2012.

http://www.jointcommission.org/multimedia/national-summit-on-overuse-dr-rosof/

Koch C G, Li Liang, Sessler D I, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229-1239.

Premier. Best practices in blood utilization. October 2012.

https://www.premierinc.com/about/news/12-oct/blood_white_paper_207pm_10032012.pdf

Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50:753-765.

US Department of Health and Human Services Advisory Committee for Blood Safety and Availability: 40th Meeting Minutes, June 8, 2011.

http://nih.granicus.com/DocumentViewer.php?file=nih_279c20e5-c8ef-4e28-b457-d86995ff40fa.pdf

US Department of Health and Human Services and AABB 2009 National Blood Collection and Utilization Survey Report.

http://www.aabb.org/programs/biovigilance/nbcus/Documents/09-nbcus-report.pdf

Join our community

Learn More
Video Spotlight
Live chat by BoldChat